The effect of sitagliptin on reducing BMI and the occurrence of hypoglycemia in obese patients with insulin treatment-induced diabetes mellitus might be correlated with decreased leptin levels and increased adiponectin levels [27]. The gene discussed is ADIPOQ; the disease is diabetes mellitus.